Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
4.320
-0.060 (-1.37%)
Sep 10, 2026, 3:00 PM CST
SHA:600572 Market Cap
SHA:600572 has a market cap or net worth of 11.12 billion as of September 9, 2026. Its market cap has increased by 0.19% in one year.
Market Cap
11.12B
Enterprise Value
10.44B
Revenue
6.82B
Ranking
n/a
PE Ratio
21.73
Stock Price
4.32
ChartMarket Cap Chart
Since April 12, 2004, SHA:600572's market cap has increased from 2.01B to 11.12B, an increase of 454.31%. That is a compound annual growth rate of 7.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 11.12B | -1.62% |
| Dec 31, 2025 | 11.30B | -3.24% |
| Dec 31, 2024 | 11.68B | -10.01% |
| Dec 29, 2023 | 12.98B | 6.77% |
| Dec 30, 2022 | 12.16B | -5.40% |
| Dec 31, 2021 | 12.85B | 6.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Medicine | 12.28B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.20B |
| Guobang Pharma | 11.97B |
| Wedge Industrial | 11.50B |
| Shanghai Shyndec Pharmaceutical | 11.36B |
| Beijing Aosaikang Pharmaceutical | 11.29B |
| Shenzhen Chipscreen Biosciences | 11.24B |
| Henan Lingrui Pharmaceutical | 11.08B |